Exelixis, Inc.
NASDAQExelixis enters the post-earnings stretch with a clean beat behind it, a $750 million buyback in hand, and a fresh pipeline catalyst — yet short sellers have quietly added to their positions all month, setting up a genuine tug-of-war between the bulls and the bears. The company reported Q1 adjusted EPS of $0.87, well above the $0.70 consensus, on sales of $610.8 million that nudged…
Snapshot as of 6 May 2026
Exelixis enters the post-earnings stretch with a clean beat behind it, a $750 million buyback in hand, and a fresh pipeline catalyst — yet short sellers have quietly added to their positions all month, setting up a…
EXEL heads into its May 5 Q1 results with short sellers at their most aggressive in months — and the stock down 4.6% on the week despite an otherwise healthy April. The short interest story is the week's defining…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for EXEL — free to start on ORTEX.
Sign up for free →Open EXEL on ORTEX